Patricia Forgez
Inserm · 135 works · 3,811 citations · h-index 33
Top works
- Quantitative RT-PCR: Limits and Accuracy
- Distribution and characterization of the serum lipoproteins and apoproteins in the mouse, Mus musculus.
- Further resolution of the low density lipoprotein spectrum in normal human plasma: physicochemical characteristics of discrete subspecies separated by density gradient ultracentrifugation.
- A density gradient study of the lipoprotein and apolipoprotein distribution in the chicken, Gallus domesticus
- The lipid transport system in the mouse, Mus musculus: isolation and characterization of apolipoproteins B, A-I, A-II, and C-III.
- Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancer
- Expression of Neurotensin and NT1 Receptor in Human Breast Cancer: A Potential Role in Tumor Progression
- Renin-angiotensin system at the heart of COVID-19 pandemic
- Preresection serum C-reactive protein measurement and survival among patients with resectable non–small cell lung cancer
- Automated image analyzing system for the quantitative study of living cells in culture
- Expression of the human apolipoprotein E gene suppresses steroidogenesis in mouse Y1 adrenal cells.
- Neurotensin Receptor 1 Determines the Outcome of Non–Small Cell Lung Cancer
- The potential use of the neurotensin high affinity receptor 1 as a biomarker for cancer progression and as a component of personalized medicine in selective cancers
- Anticancer Activity of BIM-46174, a New Inhibitor of the Heterotrimeric Gα/Gβγ Protein Complex
- Distinct functional characteristics of levocabastine sensitive rat neurotensin NT2 receptor expressed in Chinese hamster ovary cells
- Plasma lipoproteins and apolipoproteins in the preruminant calf, Bos spp: density distribution, physicochemical properties, and the in vivo evaluation of the contribution of the liver to lipoprotein homeostasis.
- Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy
- The Neurotensin Receptor-1 Pathway Contributes to Human Ductal Breast Cancer Progression
- Neurotensin Agonist Induces Differential Regulation of Neurotensin Receptor mRNA
- Neurotensin receptor 1 gene activation by the Tcf/β-catenin pathway is an early event in human colonic adenomas